BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carubelli V, Lombardi C, Gorga E, Ravera A, Metra M, Mentz RJ. Cardiorenal Interactions. Heart Failure Clinics 2016;12:335-47. [DOI: 10.1016/j.hfc.2016.03.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Lei Y, Li Y, Zhang J, Tang H. Wnt/β‐catenin signalling mediates cardiac hypertrophy in type 4 cardiorenal syndrome. Nephrology 2021;26:549-60. [DOI: 10.1111/nep.13848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Reina-couto M, Afonso J, Carvalho J, Morgado L, Ronchi FA, de Oliveira Leite AP, Dias CC, Casarini DE, Bettencourt P, Albino-teixeira A, Morato M, Sousa T. Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment. Biomedicine & Pharmacotherapy 2021;133:110938. [DOI: 10.1016/j.biopha.2020.110938] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
3 Xanthopoulos A, Triposkiadis F, Starling RC. Cardiorenal Syndrome in a Patient with Mechanical Circulatory Support. Cardiorenal Syndrome in Heart Failure 2020. [DOI: 10.1007/978-3-030-21033-5_16] [Reference Citation Analysis]
4 Mangoni AA, Jarmuzewska EA. The influence of heart failure on the pharmacokinetics of cardiovascular and non-cardiovascular drugs: a critical appraisal of the evidence. Br J Clin Pharmacol 2019;85:20-36. [PMID: 30194701 DOI: 10.1111/bcp.13760] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
5 Carubelli V, Metra M, Lund LH. Negotiating renal dysfunction when treating patients with heart failure. Expert Rev Cardiovasc Ther 2018;16:113-22. [PMID: 29292652 DOI: 10.1080/14779072.2018.1422178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sumler M, Vadlamudi R. Preanesthetic evaluation of the patient with end-stage heart failure. Best Pract Res Clin Anaesthesiol 2017;31:179-88. [PMID: 29110791 DOI: 10.1016/j.bpa.2017.06.001] [Reference Citation Analysis]
7 Chang-Chien C, Chuang GT, Tsai IJ, Chiang BL, Yang YH. A large retrospective review of persistent proteinuria in children. J Formos Med Assoc 2018;117:711-9. [PMID: 28943081 DOI: 10.1016/j.jfma.2017.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
8 Cernea S. Heart Failure and Chronic Kidney Disease in Type 2 Diabetes. Journal of Interdisciplinary Medicine 2016;1:252-8. [DOI: 10.1515/jim-2016-0066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]